ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $659,105 | -73.2% | 30,500 | -76.0% | 0.00% | – |
| Q3 2022 | $2,461,000 | +24.5% | 127,125 | +27.6% | 0.00% | – |
| Q2 2022 | $1,977,000 | -58.5% | 99,594 | -37.6% | 0.00% | -100.0% |
| Q1 2022 | $4,761,000 | +28.2% | 159,616 | +0.1% | 0.00% | – |
| Q4 2021 | $3,714,000 | -43.0% | 159,496 | -23.7% | 0.00% | – |
| Q3 2021 | $6,518,000 | +7.1% | 208,922 | +20.8% | 0.00% | – |
| Q2 2021 | $6,086,000 | +45.4% | 172,998 | +45.7% | 0.00% | – |
| Q1 2021 | $4,185,000 | -40.3% | 118,727 | -36.5% | 0.00% | – |
| Q4 2020 | $7,008,000 | -65.1% | 186,846 | -69.0% | 0.00% | -100.0% |
| Q3 2020 | $20,091,000 | +766.7% | 602,072 | +587.9% | 0.00% | – |
| Q2 2020 | $2,318,000 | +211.1% | 87,517 | +92.3% | 0.00% | – |
| Q1 2020 | $745,000 | +153.4% | 45,500 | +209.5% | 0.00% | – |
| Q3 2019 | $294,000 | -7.0% | 14,700 | +50.0% | 0.00% | – |
| Q1 2019 | $316,000 | -69.1% | 9,800 | -68.8% | 0.00% | – |
| Q1 2018 | $1,023,000 | – | 31,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 1,704,330 | $60,504,000 | 1.59% |
| Birchview Capital, LP | 38,000 | $1,349,000 | 0.92% |
| Virtus ETF Advisers LLC | 24,688 | $876,000 | 0.77% |
| BVF INC/IL | 220,000 | $7,810,000 | 0.76% |
| SECTORAL ASSET MANAGEMENT INC | 172,803 | $6,135,000 | 0.69% |
| Chicago Capital, LLC | 134,748 | $4,784,000 | 0.39% |
| Artal Group S.A. | 500,000 | $17,750,000 | 0.38% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $25,432,000 | 0.33% |
| Eversept Partners, LP | 18,029 | $640,030 | 0.29% |
| HEARTLAND ADVISORS INC | 125,000 | $4,438,000 | 0.29% |